Van Eck Associates Corp Viatris Inc Transaction History

Van Eck Associates Corp

$88.3 Billion
Q2 2025

A detailed history of Van Eck Associates Corp transactions in Viatris Inc stock. As of the latest transaction made, Van Eck Associates Corp holds 504,426 shares of VTRS stock, worth $5.24 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

504,426

Previous 1,873,726 73.08%

Holding current value

$5.24 Million

Previous $16.3 Million 72.4%

% of portfolio

0.01%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$7.26 - $9.12 $9.94 Million - $12.5 Million	-1,369,300 Reduced 73.08%	504,426 $4.5 Million
Q1 2025 May 15, 2025	BUY	$8.68 - $12.42 $7.48 Million - $10.7 Million	862,237 Added 85.24%	1,873,726 $16.3 Million
Q4 2024 Jan 29, 2025	SELL	$11.32 - $13.37 $1.8 Million - $2.13 Million	-159,141 Reduced 13.59%	1,011,489 $12.6 Million
Q3 2024 Oct 29, 2024	BUY	$10.32 - $12.13 $1.61 Million - $1.89 Million	156,201 Added 15.4%	1,170,630 $13.5 Million
Q2 2024 Jul 31, 2024	BUY	$10.05 - $12.02 $474,902 - $567,993	47,254 Added 4.89%	1,014,429 $10.8 Million
Q1 2024 Apr 30, 2024	SELL	$11.27 - $13.53 $3.18 Million - $3.82 Million	-282,195 Reduced 22.59%	967,175 $11.5 Million
Q4 2023 Feb 05, 2024	SELL	$8.77 - $10.85 $4.17 Million - $5.16 Million	-475,169 Reduced 27.55%	1,249,370 $13.5 Million
Q3 2023 Nov 08, 2023	SELL	$9.59 - $11.35 $543,398 - $643,125	-56,663 Reduced 3.18%	1,724,539 $17 Million
Q2 2023 Aug 03, 2023	BUY	$9.02 - $10.29 $4.87 Million - $5.55 Million	539,436 Added 43.44%	1,781,202 $17.8 Million
Q1 2023 May 03, 2023	SELL	$9.2 - $12.26 $9.72 Million - $12.9 Million	-1,056,139 Reduced 45.96%	1,241,766 $11.9 Million
Q4 2022 Feb 08, 2023	BUY	$8.72 - $11.56 $2.62 Million - $3.47 Million	300,343 Added 15.04%	2,297,905 $25.6 Million
Q3 2022 Oct 27, 2022	SELL	$8.48 - $11.13 $2.54 Million - $3.33 Million	-299,610 Reduced 13.04%	1,997,562 $17 Million
Q2 2022 Aug 03, 2022	BUY	$9.95 - $12.27 $7.16 Million - $8.82 Million	719,175 Added 45.58%	2,297,172 $24.1 Million
Q1 2022 May 10, 2022	BUY	$9.81 - $15.4 $2.77 Million - $4.35 Million	282,666 Added 21.82%	1,577,997 $17.2 Million
Q4 2021 Jan 26, 2022	BUY	$12.09 - $14.68 $3.13 Million - $3.81 Million	259,285 Added 25.03%	1,295,331 $17.5 Million
Q3 2021 Nov 03, 2021	BUY	$13.25 - $15.13 $4.55 Million - $5.2 Million	343,642 Added 49.63%	1,036,046 $14 Million
Q2 2021 Aug 10, 2021	SELL	$12.97 - $16.15 $658,447 - $819,887	-50,767 Reduced 6.83%	692,404 $9.9 Million
Q1 2021 May 13, 2021	BUY	$13.59 - $18.54 $1.28 Million - $1.75 Million	94,434 Added 14.56%	743,171 $10.4 Million
Q4 2020 Feb 09, 2021	BUY	$14.3 - $18.74 $9.28 Million - $12.2 Million	648,737 New	648,737 $12.2 Million

Others Institutions Holding VTRS

# of Institutions

1,140

Shares Held

973M

Call Options Held

7.62M

Put Options Held

2.97M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $12.6B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.

Account

Van Eck Associates Corp Viatris Inc Transaction History